Safety and Efficacy of Perioperative Use of Evolocumab in Myocardial Infarction Patients: Study Protocol for a Multicentre Randomized Controlled Trial-Reference-Cited by-同舟云学术

Safety and Efficacy of Perioperative Use of Evolocumab in Myocardial Infarction Patients: Study Protocol for a Multicentre Randomized Controlled Trial

Published:2021-02-27 Issue:4 Volume:38 Page:1801-1810
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Luan Yi,Wang Min,Zhao Liding,Xu Tian,Fu Guosheng,Zhang Wenbin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-021-01662-5.pdf

Reference19 articles.

1. Vagnarelli F, Taglieri N, Ortolani P, et al. Long-term outcomes and causes of death after acute coronary syndrome in patients in the Bologna, Italy, area. Am J Cardiol. 2015;115:171–7.

2. Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017;135:e146–603.

3. Berwanger O, Santucci EV, De Silva BEPGM, et al. Effect of loading dose of atorvastatin prior to planned percutaneous coronary intervention on major adverse cardiovascular events in acute coronary syndrome: the SECURE-PCI randomized clinical trial. JAMA. 2018;319:1331–40.

4. Yun KH, Oh SK, Rhee SJ, et al. 12-month follow-up results of high dose rosuvastatin loading before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol. 2011;146:68–72.

5. Jang Y, Zhu J, Ge J, et al. Preloading with atorvastatin before percutaneous coronary intervention in statin-naïve Asian patients with non-ST elevation acute coronary syndromes: a randomized study. J Cardiol. 2014;63:335–43.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress on the natural products in the intervention of myocardial infarction;Frontiers in Pharmacology;2024-08-22

2. Exploring the role and mechanism of hyperoside against cardiomyocyte injury in mice with myocardial infarction based on JAK2/STAT3 signaling pathway;Phytomedicine;2023-12

3. Nanomaterials-Mediated Therapeutics and Diagnosis Strategies for Myocardial Infarction;Frontiers in Chemistry;2022-07-07